AU2002229074A1 - Selective cox-2 inhibition from plant extracts - Google Patents

Selective cox-2 inhibition from plant extracts

Info

Publication number
AU2002229074A1
AU2002229074A1 AU2002229074A AU2907402A AU2002229074A1 AU 2002229074 A1 AU2002229074 A1 AU 2002229074A1 AU 2002229074 A AU2002229074 A AU 2002229074A AU 2907402 A AU2907402 A AU 2907402A AU 2002229074 A1 AU2002229074 A1 AU 2002229074A1
Authority
AU
Australia
Prior art keywords
inhibition
plant extracts
selective cox
cox
selective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002229074A
Other languages
English (en)
Inventor
Susan L. Hummert
Mark G. Obukowicz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia LLC
Original Assignee
Pharmacia LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia LLC filed Critical Pharmacia LLC
Publication of AU2002229074A1 publication Critical patent/AU2002229074A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Plant Substances (AREA)
AU2002229074A 2000-12-15 2001-12-13 Selective cox-2 inhibition from plant extracts Abandoned AU2002229074A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30420700P 2000-12-15 2000-12-15
US60/304,207 2000-12-15
PCT/US2001/048650 WO2002047706A2 (fr) 2000-12-15 2001-12-13 Inhibition sélective de la cox-2 au moyen d'extraits végétaux

Publications (1)

Publication Number Publication Date
AU2002229074A1 true AU2002229074A1 (en) 2002-06-24

Family

ID=23175530

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002229074A Abandoned AU2002229074A1 (en) 2000-12-15 2001-12-13 Selective cox-2 inhibition from plant extracts

Country Status (5)

Country Link
US (2) US20020136784A1 (fr)
EP (1) EP1401460A2 (fr)
JP (1) JP2004529079A (fr)
AU (1) AU2002229074A1 (fr)
WO (1) WO2002047706A2 (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7972632B2 (en) * 2003-02-28 2011-07-05 Unigen Pharmaceuticals, Inc. Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors
US20030165588A1 (en) 2002-03-01 2003-09-04 Unigen Pharmaceuticals, Inc. Identification of free-B-ring flavonoids as potent COX-2 inhibitors
US7108868B2 (en) 2002-03-22 2006-09-19 Unigen Pharmaceuticals, Inc. Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
US8034387B2 (en) 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
US8945518B2 (en) * 2002-04-30 2015-02-03 Unigen, Inc. Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions
WO2003092599A2 (fr) 2002-04-30 2003-11-13 Unigen Pharmaceuticals, Inc. Formulation pour un melange de flavonoides et de flavanes sans noyau b utilise comme agent therapeutique
JP2004196696A (ja) * 2002-12-18 2004-07-15 Kyowa Hakko Kogyo Co Ltd 関節炎の予防剤または治療剤
FR2851919A1 (fr) * 2003-03-03 2004-09-10 Lmd Lignanes utilisables comme inhibiteurs de cathepsines et leurs applications
CA2521429A1 (fr) * 2003-04-04 2004-10-21 Unigen Pharmaceuticals, Inc. Formulation destinee a inhiber la cyclooxygenase (cox) et la lipoxygenase (lox) utilisee dans les soins cutanes
FR2854799A1 (fr) * 2003-05-16 2004-11-19 Cognis France Sa Utilisation d'extraits des graines de plantes appartenant au genre adenanthera pour la fabrication de preparations cosmetiques et/ou dermatologiques
EP1660109A4 (fr) * 2003-09-02 2009-04-08 Unigen Pharmaceuticals Inc Formulation d'un melange de flavonoides et de flavanes a cycle b utilise dans la prevention et le traitement du declin cognitif et des anomalies de la memoire dues a l'age
WO2005070442A1 (fr) * 2003-12-22 2005-08-04 Council Of Scientific & Industrial Research Composition synergique de traitement de l'hyperlipidemie
JP4836418B2 (ja) * 2004-07-29 2011-12-14 丸善製薬株式会社 抗酸化剤、抗炎症剤、美白剤及び皮膚化粧料
KR100545304B1 (ko) * 2004-09-01 2006-05-08 주식회사 유니젠 아선약을 포함하는 운카리아 속 식물, 또는 이의 황금및/또는 녹차의 배합물을 포함하는 사이클로옥시게나제및/또는 5-리폭시게나제 억제용 조성물
US20060198872A1 (en) * 2005-03-07 2006-09-07 Chioma Ikonte Plant based dietary supplement for improving the duration and quality of sleep
EP2061327B1 (fr) 2006-05-01 2016-10-05 Napo Pharmaceuticals, Inc. Compositions pour le traitement ou la prévention de l'affection abdominale inflammatoire
US7282224B1 (en) 2006-06-09 2007-10-16 Guthy-Renker Corporation Pain relief composition
KR100761248B1 (ko) 2006-10-12 2007-10-04 주식회사 유니젠 대나무 및 황금 추출물을 유효성분으로 함유하는 아토피성피부염 치료를 위한 조성물
US20080107747A1 (en) * 2006-10-23 2008-05-08 Roederer Joy E Pain relief composition
KR100791108B1 (ko) 2006-11-06 2008-01-03 제주대학교 산학협력단 방사선 방호효과를 갖는 담팔수 분획농축물과 그 제조방법
FR2922765B1 (fr) * 2007-10-25 2014-11-28 Inst Rech Developpement Ird Utilisation d'une huile essentielle pour la preparation d'une composition cosmetique ou pharmaceutique
KR100982022B1 (ko) * 2008-03-11 2010-09-13 한동열 신경세포 손상의 예방 또는 치료용 조성물
FR2943247B1 (fr) 2009-03-20 2012-11-30 Natura Cosmeticos Sa Procede pour obtenir des substances insolubles a partir de precipites d'extrait de genipap, substances ainsi obtenues et leurs utilisations
KR101057483B1 (ko) 2009-04-09 2011-08-17 한동열 9-히드록시-알파-토코페론을 포함하는 신경세포 손상의 예방 또는 치료용 조성물
MX2012002437A (es) 2009-08-26 2012-06-27 Mary Kay Inc Formulaciones topicas para el cuidado de la piel que comprenden extractos de plantas.
KR101167677B1 (ko) * 2009-09-21 2012-07-20 한국생명공학연구원 엘리오카퍼스 페티오라투스 추출물을 함유하는 염증성 질환 예방 및 치료용 조성물
US9220675B2 (en) 2010-09-09 2015-12-29 Mary Kay Inc. Topical skin care formulations comprising plant extracts
WO2012077976A2 (fr) * 2010-12-07 2012-06-14 한국생명공학연구원 Composition anti-âge contenant un extrait d'elaeocarpus petiolatus ou une fraction de celui-ci comme principe actif
KR101425560B1 (ko) 2010-12-07 2014-08-04 한국생명공학연구원 엘리오카퍼스 페티오라투스 추출물 또는 이의 분획물을 유효성분으로 함유하는 항산화용 조성물
DE102011109522A1 (de) * 2011-08-05 2013-02-07 Merck Patent Gmbh Extrakte aus Tradescantia virginiana
US8632827B2 (en) 2011-12-13 2014-01-21 Avon Products, Inc Modulation of thymosin beta-4 in skin
MX349544B (es) * 2011-12-13 2017-08-02 Avon Prod Inc Extractos de maesa japonica y métodos de uso.
TWI637751B (zh) * 2012-12-11 2018-10-11 美商愛芳製品公司 山桂花(maesa japonica)萃取物及使用方法
JP2014177454A (ja) * 2013-02-18 2014-09-25 Kagoshima Univ ねじめびわ茶抽出物を含有する飲食品及び医薬品
JP2016132633A (ja) * 2015-01-19 2016-07-25 農業生産法人 有限会社十津川農場 ねじめびわ茶のアルツハイマー症予防又は治療作用
JP6485836B2 (ja) * 2015-12-28 2019-03-20 株式会社佐藤園 イグサ由来シクロオキシゲナーゼ−2阻害剤
TWI656879B (zh) * 2016-01-26 2019-04-21 財團法人工業技術研究院 用於治療或減緩自體免疫疾病及/或其併發症及/或腎炎的醫藥組成物以及其有效成分之用途
WO2017191581A1 (fr) 2016-05-03 2017-11-09 Tauderma Sa Extraits de saxifraga pour utilisation cosmétique ou thérapeutique sur la peau
KR101806031B1 (ko) 2016-07-11 2017-12-08 한양대학교 에리카산학협력단 마카커진 c 또는 이의 유도체를 함유하는 항염증 활성 조성물 및 이의 제조방법
KR102015448B1 (ko) * 2017-12-08 2019-08-28 성균관대학교산학협력단 검팽나무 추출물을 유효성분으로 포함하는 항염증 조성물
KR102284073B1 (ko) * 2019-10-14 2021-08-02 한국해양과학기술원 항염증 활성을 갖는 남극 지의류 움빌리카리아 안타티카 추출물 및 이를 함유하는 조성물

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4324785A (en) * 1980-05-20 1982-04-13 Emma S. Stevens Foot powder
US4313958A (en) * 1980-10-24 1982-02-02 The Procter & Gamble Company Method of producing analgesia
JPS5824523A (ja) * 1981-08-07 1983-02-14 Terumo Corp 抗悪性新生物剤
JPS5936619A (ja) * 1982-08-23 1984-02-28 Tsumura Juntendo Inc 制癌補助剤
US4767626A (en) * 1985-03-11 1988-08-30 Theodore Cheng Remedy for anemia and arthritis
US5380738A (en) * 1993-05-21 1995-01-10 Monsanto Company 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
US5344991A (en) * 1993-10-29 1994-09-06 G.D. Searle & Co. 1,2 diarylcyclopentenyl compounds for the treatment of inflammation
DK0924201T3 (da) * 1993-11-30 2002-05-21 Searle & Co Tricyclisk substitueret pyrazolylbenzensulfonamider og deres anvendelse som cyclooxygenase II-inhibitorer
US5466823A (en) * 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
US5393790A (en) * 1994-02-10 1995-02-28 G.D. Searle & Co. Substituted spiro compounds for the treatment of inflammation
US5824312A (en) * 1994-03-10 1998-10-20 Imarx Pharmaceutical Corp. Sunscreen agents from natural sources
US5633272A (en) * 1995-02-13 1997-05-27 Talley; John J. Substituted isoxazoles for the treatment of inflammation
JP2732504B2 (ja) * 1995-03-08 1998-03-30 農林水産省中国農業試験場長 アラキドン酸代謝活性阻害剤とその製造法
US5762963A (en) * 1995-06-07 1998-06-09 Emory University Method and compositions for controlling oral and pharyngeal pain using capsaicinoids
JPH0967360A (ja) * 1995-08-28 1997-03-11 Terumo Corp 癌遺伝子機能抑制剤
PL195955B1 (pl) * 1996-04-12 2007-11-30 Searle & Co Związek, pochodna benzenosulfonamidu, sposób jegowytwarzania, kompozycja farmaceutyczna zawierająca go oraz jego zastosowanie
DK1007067T3 (da) * 1996-10-21 2002-05-06 Eurovita As Farmaceutiske præparater indeholdende Parthenium integrifolium eller dele deraf eller en ekstrakt bestanddel deraf, anvendelsen af et sådant plantemateriale til fremstilling af ...
US5811425A (en) * 1997-03-04 1998-09-22 Abbott Laboratories Heterocyclic compounds as COX-2 inhibitors
JP4231559B2 (ja) * 1997-04-23 2009-03-04 オリザ油化株式会社 リポキシゲナーゼ阻害剤
EP0984781A1 (fr) * 1997-05-27 2000-03-15 Algos Pharmaceutical Corporation Composition de medicament analgesique contenant un capsaicinoide et un agent de potentialisation de celui-ci
AUPP797598A0 (en) * 1998-12-30 1999-01-28 Butters, Desley Therapeutic agent
US6194469B1 (en) * 1998-12-11 2001-02-27 Board Of Trustees Operating Michigan State Univeristy Method for inhibiting cyclooxygenase and inflammation using cherry bioflavonoids
JP4397991B2 (ja) * 1999-02-16 2010-01-13 株式会社ロッテ 抗発癌プロモーター剤
US20010006686A1 (en) * 1999-03-19 2001-07-05 David G. Corley Inflammatory mediation obtained from atractylodes lancea
CA2414094A1 (fr) * 1999-05-27 2000-12-07 Armadillo Pharmaceuticals, Inc. Preparations pharmaceutiques de substances bioactives extraites de sources naturelles
US6348501B1 (en) * 1999-09-29 2002-02-19 Medical Merchandising, Inc. Lotion compositions utilizing capsaicin
US6197823B1 (en) * 1999-09-29 2001-03-06 Medical Merchandising, Inc. Pain reliever and method of use
US6310091B1 (en) * 2000-09-14 2001-10-30 The United States Of America As Represented By The Secretary Of Agriculture Fungicidal saponin, CAY-1, and isolation thereof from Capsium species fruit

Also Published As

Publication number Publication date
US20040197429A1 (en) 2004-10-07
US20020136784A1 (en) 2002-09-26
EP1401460A2 (fr) 2004-03-31
WO2002047706A2 (fr) 2002-06-20
WO2002047706A3 (fr) 2003-12-31
JP2004529079A (ja) 2004-09-24

Similar Documents

Publication Publication Date Title
AU2002229074A1 (en) Selective cox-2 inhibition from plant extracts
AU2002230985A1 (en) Selective cox-2 inhibition from edible plant extracts
AU2002227302A1 (en) Chromatherapy shower system
AU3799401A (en) Facilitating drainage
AU7409801A (en) Hydroelectric plant
AU2002216774A1 (en) Eas marker
AU2001281666A1 (en) Lavatory
AUPR143100A0 (en) Plant transformation
AU2001263697A1 (en) Water fitting
AU2002229086A1 (en) Selective cox-2 inhibition from non-edible plant extracts
AU2002210725A1 (en) Watering system
AU2002253937A1 (en) Soil redeposition inhibition agents and systems
AU2002212539A1 (en) Pipe construction system
AU2001277619A1 (en) Pipe assembly
AU2001264924A1 (en) Plant anchor
AU2002223849A1 (en) Pipe fitting
AU2001282309A1 (en) Pipe assembly
AUPR158100A0 (en) Valve system
AU2002221819A1 (en) Passivation method
AU2002217641A1 (en) Furnace plant
AU3542101A (en) Sanitary system
AU2001295101A1 (en) Water trap
AU2001254644A1 (en) Flexibly insertable covering
AU4555099A (en) Plant extract
AU2001268670A1 (en) Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of erk-5